News on Lorus Therapeutics from BioPortfolio.com http://www.BioPortfolio.com Consolidated Lorus Therapeutics news from BioPortfolio.com Tue, 09 Feb 2010 21:37:43 GMT en Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=0&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012576&HITNO=0&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012576&THISHREF=http://c.moreover.com/click/here.pl%3fz2523467433%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Finance: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=1&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012527&HITNO=1&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012527&THISHREF=http://c.moreover.com/click/here.pl%3fz2523455059%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013117&HITNO=2&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013117&THISHREF=http://c.moreover.com/click/here.pl%3fz2523615678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4013117&HITNO=2&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4013117&THISHREF=http://c.moreover.com/click/here.pl%3fz2523615678%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPhoenix Business Journal: Reportlinker Adds Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharmahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012525&HITNO=3&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012525&THISHREF=http://c.moreover.com/click/here.pl%3fz2523454846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012525&HITNO=3&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012525&THISHREF=http://c.moreover.com/click/here.pl%3fz2523454846%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Ribonucleic Acid (RNA) Therapeutics - Strong Potential To Address Unmet Needs In Pharma - New Market Report Puhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005377&HITNO=4&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005377&THISHREF=http://c.moreover.com/click/here.pl%3fz2520344895%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005377&HITNO=4&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005377&THISHREF=http://c.moreover.com/click/here.pl%3fz2520344895%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialSpin: Ribonucleic Acid (RNA) Therapeutics - Strong Potential To Address Unmet Needs In Pharma - New Market Report Publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005337&HITNO=5&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005337&THISHREF=http://c.moreover.com/click/here.pl%3fz2520329072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005337&HITNO=5&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005337&THISHREF=http://c.moreover.com/click/here.pl%3fz2520329072%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialWire: R&D Pipeline News. Volume 6, Issue 3: PSMA & PSA Targeted Therapyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967112&HITNO=6&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967112&THISHREF=http://c.moreover.com/click/here.pl%3fz2499444518%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967112&HITNO=6&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967112&THISHREF=http://c.moreover.com/click/here.pl%3fz2499444518%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Lorus Therapeutics Reports Second Quarter Results for Fiscal Year 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3908400&HITNO=7&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3908400&THISHREF=http://c.moreover.com/click/here.pl%3fz2467839421%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3908400&HITNO=7&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3908400&THISHREF=http://c.moreover.com/click/here.pl%3fz2467839421%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Lorus Therapeutics Q2 loss drops to $1.3M from $2.3M; revenues more than doublehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3908559&HITNO=8&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3908559&THISHREF=http://c.moreover.com/click/here.pl%3fz2467913475%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3908559&HITNO=8&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3908559&THISHREF=http://c.moreover.com/click/here.pl%3fz2467913475%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: Canadian earnings declared Thursday: Astral, Shaw, Sandvine, Lorushttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909901&HITNO=9&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909901&THISHREF=http://c.moreover.com/click/here.pl%3fz2468631907%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3909901&HITNO=9&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3909901&THISHREF=http://c.moreover.com/click/here.pl%3fz2468631907%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioscience Technology Online: Lorus Therapeutics Announces Positive Result in Its Phase II Clinical Study of LOR-2040 in Acute Myeloid Leukehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3714575&HITNO=10&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3714575&THISHREF=http://c.moreover.com/click/here.pl%3fz2370427744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3714575&HITNO=10&MSIZE=11&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Lorus%20Therapeutics&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3714575&THISHREF=http://c.moreover.com/click/here.pl%3fz2370427744%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: